New Zealand markets open in 9 hours 36 minutes

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.6400-0.0300 (-1.12%)
At close: 04:00PM EST
2.6600 +0.02 (+0.76%)
After hours: 04:16PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
49,759
130,492
31.238
0
0
Operating expenses
Research development
148,631
152,899
136.734
103.52
60,393
Selling general and administrative
37,944
37,539
35.915
23.029
18,457
Total operating expenses
186,575
190,438
172.649
126.549
78,850
Operating income or loss
-136,816
-59,946
-141.411
-126.549
-78,850
Interest expense
8,379
6,370
3.358
3.506
3,553
Total other income/expenses net
14,195
2,858
19.795
0.28
-4,124
Income before tax
-131,000
-63,458
-124.974
-129.775
-86,527
Income tax expense
399
544
0
0
0
Income from continuing operations
-131,399
-64,002
-124.974
-129.775
-86,527
Net income
-131,399
-64,002
-124.974
-129.775
-86,527
Net income available to common shareholders
-131,399
-64,002
-124.974
-129.775
-87,046
Basic EPS
-0.05
-0.89
-2.01
-3.61
-2.18
Diluted EPS
-0.05
-0.89
-2.01
-3.61
-2.18
Basic average shares
83,902
71,954
62,236
35,997
39,734
Diluted average shares
83,902
71,954
62,236
35,997
39,734